Andrew G. Spencer

发表

Building capacity and integrating training, education and experience: The Fire Learning Network's prescribed burn training exchanges

Andrew G. Spencer, 2014 .

Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD.

Andrew G. Spencer, D. Charmot, M. Navre, 2015, Journal of the American Society of Nephrology : JASN.

Pharmacologic inhibition of intestinal sodium uptake: a gut centric approach to sodium management

Andrew G. Spencer, P. Greasley, 2015, Current opinion in nephrology and hypertension.

Preclinical and Healthy Volunteer Studies of Potential Drug–Drug Interactions Between Tenapanor and Phosphate Binders

Andrew G. Spencer, D. Charmot, K. Kozuka, 2016, Clinical pharmacology in drug development.

Design of Gut-Restricted Thiazolidine Agonists of G Protein-Coupled Bile Acid Receptor 1 (GPBAR1, TGR5).

Andrew G. Spencer, J. Caldwell, D. Charmot, 2018, Journal of medicinal chemistry.

Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.

Peter B. Madrid, Andrew G. Spencer, C. Khosla, 2011, Bioorganic & medicinal chemistry letters.

Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials

Andrew G. Spencer, M. Garber, D. Adelman, 2012, Digestive Diseases and Sciences.

Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.

Andrew G. Spencer, C. Khosla, Michael T. Bethune, 2007, Gastroenterology.

Intestinal Inhibition of the Na+/H+ Exchanger 3 Prevents Cardiorenal Damage in Rats and Inhibits Na+ Uptake in Humans

Andrew G. Spencer, D. Charmot, M. Navre, 2014, Science Translational Medicine.

Synthetic glycoprotein mimics inhibit L-selectin-mediated rolling and promote L-selectin shedding.

Andrew G. Spencer, R. Alon, L. Kiessling, 2004, Chemistry & biology.

RDX5791, a First-in-Class Minimally Systemic NHE3 Inhibitor in Clinical Development for CIC and IBS-C, Increases Intestinal Sodium Leading to Enhanced Intestinal Fluid Volume and Transit

Andrew G. Spencer, D. Charmot, M. Navre, 2011 .

Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na+/H+ Exchanger Isoform 3

Andrew G. Spencer, D. Charmot, M. Navre, 2022, ACS medicinal chemistry letters.

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

Andrew G. Spencer, G. Hammer, G. Krause, 2023, Frontiers in Endocrinology.